Stay updated on Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial
Sign up to get notified when there's something new on the Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial page.

Latest updates to the Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study locations were expanded with new sites across several US states and international sites (Western Australia, Alicante, Madrid). The HHS Vulnerability Disclosure link was removed and the page revision was updated to v3.3.3.SummaryDifference2%

- Check47 days agoChange DetectedThe PubMed publications notice on the study page was updated to the new wording 'These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study,' and the revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page no longer displays the government funding lapse notice in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedVisual/layout adjustments across the Study Details page; core study data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check98 days agoChange DetectedAdded a government funding operating-status notice and updated the version from v3.1.0 to v3.2.0; no other substantive content changes detected.SummaryDifference3%

- Check107 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

Stay in the know with updates to Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial page.